The Intriguing Regulators of Muscle Mass in Sarcopenia and Muscular Dystrophy

書誌事項

公開日
2014-08-29
資源種別
journal article
DOI
  • 10.3389/fnagi.2014.00230
公開者
Frontiers Media SA

説明

Recent advances in our understanding of the biology of muscle have led to new interest in the pharmacological treatment of muscle wasting. Loss of muscle mass and increased intramuscular fibrosis occur in both sarcopenia and muscular dystrophy. Several regulators (mammalian target of rapamycin, serum response factor, atrogin-1, myostatin, etc.) seem to modulate protein synthesis and degradation or transcription of muscle-specific genes during both sarcopenia and muscular dystrophy. This review provides an overview of the adaptive changes in several regulators of muscle mass in both sarcopenia and muscular dystrophy.

収録刊行物

被引用文献 (4)*注記

もっと見る

参考文献 (187)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

  • CRID
    1360004239446388736
  • DOI
    10.3389/fnagi.2014.00230
  • ISSN
    16634365
  • PubMed
    25221510
  • 資料種別
    journal article
  • データソース種別
    • Crossref
    • KAKEN
    • OpenAIRE

問題の指摘

ページトップへ